Meridian Bioscience Stock

Meridian Bioscience Intangible Assets

The Intangible Assets of Meridian Bioscience (VIVO) as of Sep 11, 2026 is 74.13 M USD. In the previous year, Intangible Assets was 84.15 M USD — a change of -11.91% (lower).

Intangible Assets

74.13 MUSD

YoY

-11.91%

Last updated:

Intangible Assets of Meridian Bioscience is 2026 74.13 M USD. Intangible Assets of Meridian Bioscience was 2025 84.15 M USD. It decreases by -11.91% lower compared to the previous year.

The Meridian Bioscience Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2015
5.90 M USD
Jan 1, 2016
29.90 M USD
Jan 1, 2017
26.70 M USD
Jan 1, 2018
23.10 M USD
Jan 1, 2019
60.20 M USD
Jan 1, 2020
83.20 M USD
Jan 1, 2021
84.15 M USD
Jan 1, 2022
74.13 M USD
The Meridian Bioscience Intangible Assets history
YEARIntangible AssetsYoY
74.13 MUSD-11.91%
84.15 MUSD+1.14%
83.20 MUSD+38.21%
60.20 MUSD+160.61%
23.10 MUSD-13.48%
26.70 MUSD-10.70%
29.90 MUSD+406.78%
5.90 MUSD-24.36%
7.80 MUSD
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Intangible Assets of Meridian Bioscience is 74.13 M USD in 2026.

Intangible Assets of Meridian Bioscience changed from 84.15 M USD to 74.13 M USD, representing a -11.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Meridian Bioscience

All Key Metrics — Meridian Bioscience